Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.
Previous studies indicate that 80-95% of grafted dopamine neurons die following implantation of embryonic ventral mesencephalic tissue into the striatum. It is believed that the majority die within the first 1-3 weeks after surgery. The aim of this study was to study when and where the implanted neurons die, using the novel fluorescent stain Fluoro-Jade. Fluoro-Jade has recently been shown to stain cell bodies, dendrites, axons, and terminals of degenerating neurons. We transplanted dissociated ventral mesencephalic tissue from embryonic day 14 rat embryos into intact adult rat striatum. After perfusion and sectioning of the implanted rat brains, the number and distribution of Fluoro-Jade and tyrosine hydroxylase-positive neurons were evaluated at 6, 10, 14, and 42 days posttransplantation. Intensely Fluoro-Jade stained neurons were numerous in the grafts at 6 and 10 days after graft surgery; appeared in reduced numbers at 14 days; and had disappeared by the 42-day time point. The number of surviving tyrosine hydroxylase-positive, dopaminergic neurons in the grafts did not change between 6 and 42 days and the low survival rate confirmed that over 90% of these neurons had died during the first week. Assessment of the distribution of neurons positive for Fluoro-Jade or tyrosine hydroxylase revealed higher numbers of neurons stained for these markers located at the periphery than the center of the grafts, and this pattern did not change over time. This study indicates that transplanted neurons continue to die up to 14 days after grafting. Since the majority of transplanted tyrosine hydroxylase-positive neurons most probably die before 6 days after transplantation, neuroprotective strategies should primarily focus on the transplantation procedure and the first week after implantation.
Emgård
M
M
Department of Physiological Sciences, Lund University, Sweden. mia.emgard_mattson@mphy.lu.se
Karlsson
J
J
Hansson
O
O
Brundin
P
P
D000818:Animals; D017209:Apoptosis; D015415:Biomarkers; D016380:Brain Tissue Transplantation; D002470:Cell Survival; D003342:Corpus Striatum / Q000473:pathology*; D004298:Dopamine / Q000032:analysis*; D018690:Excitatory Amino Acid Agonists / Q000633:toxicity; D016332:Fetal Tissue Transplantation; D005456:Fluorescent Dyes; D006085:Graft Survival; D009419:Nerve Tissue Proteins / Q000032:analysis; D009474:Neurons / Q000473:pathology* / Q000637:transplantation; D010300:Parkinson Disease / Q000601:surgery; D011184:Postoperative Period; D017378:Quinolinic Acid / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000187:drug effects / Q000196:embryology / Q000637:transplantation*; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D015415:Biomarkers; D018690:Excitatory Amino Acid Agonists; D005456:Fluorescent Dyes; D009419:Nerve Tissue Proteins; D014446:Tyrosine 3-Monooxygenase; D017378:Quinolinic Acid; D004298:Dopamine